Ramadan Experience of Individuals With Type 2 Diabetes
Randomized
The Impact of Ramadan Experiences on Treatment, Psychological and Glycemic Control Levels, and Adherence in Individuals With Type 2 Diabetes
1 other identifier
interventional
70
1 country
2
Brief Summary
This study aims to examine the effects of fasting during Ramadan on treatment adherence, psychological adjustment, and glycemic control in individuals with type 2 diabetes. While Ramadan fasting is a religious practice, it can also pose health risks such as hypoglycemia, hyperglycemia, and metabolic imbalance in individuals with diabetes. Adherence to treatment and self-care, as well as psychosocial adjustment, are crucial in the effective management of diabetes. Given that a large portion of Turkey's population is Muslim, comparing individuals with type 2 diabetes who fast and those who do not during Ramadan will contribute to improving patient care within a cultural and religious context. The findings of this study are expected to guide nurses in developing personalized, culturally sensitive care plans tailored to the needs of individuals before, during, and after Ramadan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Jan 2026
Shorter than P25 for not_applicable type-2-diabetes
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2026
CompletedFirst Submitted
Initial submission to the registry
January 6, 2026
CompletedFirst Posted
Study publicly available on registry
February 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2026
CompletedFebruary 3, 2026
January 1, 2026
2 months
January 6, 2026
January 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
1. Parametre
HbA1c 2-4 weeks before Ramadan (basic assessment).
2-4 weeks
2. Parametre
Treatment Adherence Scale, 2-4 weeks before Ramadan This scale was developed to evaluate "Patient Adherence in Type 2 Diabetes Mellitus Treatment." Validity and reliability analyses have shown it to be a valid and reliable scale. Based on the scores obtained from the scale, adherence is considered good if patients are doing what they should and not doing what they shouldn't, despite factors affecting treatment adherence. The scale: * Is administered to patients with type 2 diabetes for at least one year. • Consists of 30 items in total. * A 5-point Likert scale is used for scoring. • Patients indicate the most appropriate option for each statement on the scale using a 5-point Likert scale (Strongly agree=1, Agree=2, Partially agree=3, Disagree=4, and Strongly disagree=5). • The scale contains 13 items representing positive attitudes and 17 items representing negative attitudes. In scoring, positive items (1, 3, 5, 8, 13, 15, 16, 17, 19, 23, 25, 26, 29) are scor
2-4 weeks
3. Parametre
Psychological and Adherence Impact Scale 2-4 weeks before Ramadan. The BASE-6 was developed by Cruz et al. (2019) and it is a self-report instrument of general psychological adjustment comprising of six items. Each item assesses how a participant has been feeling in the past week. Items are rated on a 7-point scale (ranging from 1 = Not at all to 5 = Extremely). A sample item is "To what extent have you felt irritable, angry, and/or resentful this week?". Using three different adult samples, the original study demonstrated good internal consistency (α = .87-.93) and test-retest reliability (intraclass correlation was .77) over one-week period.
2-4 weeks
Post-Ramadan 2. Parametre
Treatment adherence will be assessed using the Treatment Adherence Scale for Type 2 Diabetes Mellitus, a validated and reliable 30-item, 5-point Likert scale. Patients rate each item from strongly agree to strongly disagree. Higher scores indicate better adherence to diabetes treatment.
Post-Ramadan: 1-2 months after
Secondary Outcomes (2)
Post-Ramadan 1. Parametre
Post-Ramadan: 1-2 months after
Post-Ramadan 3. Parametre
Post-Ramadan: 1-2 months after
Study Arms (2)
Experimental group: Individuals observing the fast.
EXPERIMENTALPatients in the experimental group received face-to-face dietary education from the researcher in the waiting room for approximately 15 minutes, and were given an "Information Brochure." Pre-education (pre-test) data collection tools were administered to diabetic patients. All data collection tools were administered to these patients, except for the structured Patient Information Form, which was completed one month after Ramadan 2026.
No Intervention: Control Group
NO INTERVENTIONDiabetic patients in this group were classified as a non-fasting group. No intervention was applied. Only data collection forms were administered before the study (pre-test) and after Ramadan 2026.
Interventions
The effects of fasting and non-fasting during Ramadan on treatment adherence, psychological adjustment, and glycemic control.
Eligibility Criteria
You may qualify if:
- Individuals ≥18 years of age
- Able to give informed consent
- Diagnosed with type 2 diabetes
- Planning to fast during Ramadan
You may not qualify if:
- Presence of psychiatric illness
- Presence of cognitive impairment
- Receiving additional treatments that significantly affect glucose levels (e.g., ongoing steroid therapy)
- Individuals who have decided not to fast during Ramadan
- Individuals who have stopped fasting during Ramadan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gümüşhane Universıtycollaborator
- Dilan aktepe coşarlead
Study Sites (2)
Gümüşhane Universıty
Gümüşhane, Kelkit, 2900, Turkey (Türkiye)
Gümüşhane Üniversitesi
Gümüşhane, Kelkit, 29100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dilan aktepe coşar, PhD
Gümüşhane Universıty
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Patients were randomly assigned to groups, and interviews were scheduled at different times to minimize the possibility of interaction between them. Additionally, patients were informed about the study and their consent was obtained prior to the study.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- lecture
Study Record Dates
First Submitted
January 6, 2026
First Posted
February 3, 2026
Study Start
January 3, 2026
Primary Completion
February 20, 2026
Study Completion
March 20, 2026
Last Updated
February 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual patient data will not be shared due to the need to protect participant confidentiality, the privacy of personal health information, and compliance with applicable ethical committee approval and data protection legislation (KVKK). Data will only be analyzed for scientific purposes in an anonymized and aggregated form, and there are no plans to share raw data containing individually identifying information with third parties. This approach has been adopted to protect participant rights and ensure compliance with ethical research principles.